What is he best known for?
The fields of study he is best known for:
The scientist’s investigation covers issues in Molecular biology, Cell biology, Transforming growth factor beta, Signal transduction and SMAD.
His Molecular biology study combines topics in areas such as Promoter, Neural fold, Neural plate and Gene.
He combines subjects such as Mitotic exit and Polo-like kinase with his study of Cell biology.
In Transforming growth factor beta, he works on issues like Transcription factor, which are connected to CAAT box, Activator and Response element.
His research investigates the connection with Signal transduction and areas like Endocrinology which intersect with concerns in Cell cycle.
His Transforming growth factor study combines topics from a wide range of disciplines, such as Anaphase-promoting complex, APC activator, Ubiquitin ligase and Transactivation.
His most cited work include:
- Transforming growth factor β-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells (328 citations)
- Synergistic cooperation of TFE3 and smad proteins in TGF-beta-induced transcription of the plasminogen activator inhibitor-1 gene. (269 citations)
- Interaction of the Ski Oncoprotein with Smad3 Regulates TGF-β Signaling (251 citations)
What are the main themes of his work throughout his whole career to date?
Xuedong Liu focuses on Cell biology, Transforming growth factor beta, Molecular biology, Signal transduction and Biochemistry.
The various areas that he examines in his Cell biology study include Cell cycle and Ubiquitin ligase.
His Transforming growth factor beta study integrates concerns from other disciplines, such as R-SMAD, TGF beta receptor 2, TGF alpha, Transcription factor and SMAD.
His study in the fields of Mothers against decapentaplegic homolog 3 under the domain of SMAD overlaps with other disciplines such as Dephosphorylation.
His Molecular biology research integrates issues from Erythropoietin receptor, Gene, Transfection and Protein sumoylation.
Xuedong Liu has included themes like Receptor, Enzyme-linked receptor, Cancer research and Growth inhibition in his Signal transduction study.
He most often published in these fields:
- Cell biology (57.55%)
- Transforming growth factor beta (22.64%)
- Molecular biology (19.81%)
What were the highlights of his more recent work (between 2017-2021)?
- Cell biology (57.55%)
- Cell (8.49%)
- Histone deacetylase (6.60%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Cell biology, Cell, Histone deacetylase, Cancer and Cancer research.
The Cell biology study combines topics in areas such as Receptor, Messenger RNA and Cholesterol.
His work carried out in the field of Receptor brings together such families of science as Cell signaling, Signal transduction and Optogenetics.
His Cell research incorporates themes from Therapeutic effect, Pharmacology and Membrane.
His Histone deacetylase research is multidisciplinary, incorporating perspectives in Enhancer, Gene expression, Transcriptional regulation and Histone H3 acetylation.
His study looks at the relationship between Cancer research and fields such as Histone deacetylase inhibitor, as well as how they intersect with chemical problems.
Between 2017 and 2021, his most popular works were:
- A Reversible and Repeatable Thiol-Ene Bioconjugation for Dynamic Patterning of Signaling Proteins in Hydrogels. (66 citations)
- Genome-wide dose-dependent inhibition of histone deacetylases studies reveal their roles in enhancer remodeling and suppression of oncogenic super-enhancers. (22 citations)
- Histone Deacetylase Inhibition Sensitizes PD1 Blockade-Resistant B-cell Lymphomas. (17 citations)
In his most recent research, the most cited papers focused on:
His main research concerns Cell biology, Histone deacetylase, Histone deacetylase inhibitor, MHC class II and B cell.
The study incorporates disciplines such as Ubiquitin ligase complex and Proteolysis in addition to Cell biology.
His research integrates issues of Enhancer, Gene expression, Transcriptional regulation, Histone H3 acetylation and Epigenetics in his study of Histone deacetylase.
His Histone deacetylase inhibitor research includes themes of Blockade, Lymphoma and Cancer research.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
